During continuing review of a clinical trial, the reviewing IRB for Dr. Smith terminated approval of the study after determining that the risks of conducting the study outweighed potential benefits. Dr. Smith is required to: Send a letter to all subjects notifying them of the termination. Destroy all of the investigational devices remaining at his site. Notify the FDA of the termination. Notify the sponsor of the IRB’s termination of approval of the clinical trial.
[Expert Solution]: During continuing review of a clinical trial,…
Need help with your Clinical Case Studies case study or NCLEX preparation? Connect with a verified Nursing expert now.